IP Library Granted Patent US 10,500,173
Granted Patent B2
US 10,500,173 · App. 13/163,224 · Granted Dec 10, 2019

Antimicrobial silicone-based wound dressings

Inventors: Liu Yang (Toronto, CA); Valerio DiTizio (Toronto, CA)
Assignee: COVALON TECHNOLOGIES INC.
A61K31/155
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,500,173
App. No.
13/163,224
Granted
Dec 10, 2019
Kind
B2
Abstract

Antimicrobial silicone-based dressings, such as wound dressings, are disclosed. An example dressing comprises a transparent and self-adhesive gel sheet cured from a liquid containing silicone, the sheet having dispersed therein (i) particulates of a chlorhexidine compound that is not soluble in the liquid; and (ii) at least one other antimicrobial. Methods of making the silicone-based dressings and methods of use are also disclosed.

Claims (10)

1. A dressing consisting of a transparent and self-adhesive gel sheet cured from a liquid containing silicone and formed for adhesion to a wound site or surgical site on a patient, the cured gel sheet formed of a crosslinked silicone elastomer having sufficient crosslinking between silicone polymer chains so that the gel sheet is cohesively strong thereby allowing for application and subsequent removal from the wound site or surgical site while leaving substantially no residue, the cured gel sheet having from 95 wt % to 98 wt % of the crosslinked silicone elastomer and having evenly dispersed throughout the crosslinked silicone elastomer (i) solid particulates of chlorhexidine diacetate that is not soluble in said liquid, at a concentration so as not to disrupt the crosslinking between silicone polymer chains and the self-adhesiveness and cohesive strength of the gel sheet; and (ii) chlorhexidine digluconate, and a silver agent, the silver agent photo-stabilized with a compound containing a basic nitrogen atom to complex with the silver and a dye; the total amount of chlorhexidine present in the cured gel sheet being from 2 wt % to 5 wt %, and the amount of the silver agent present in the cured gel sheet being from 0.025 wt % to 0.5 wt %.

2. The dressing of claim 1 , wherein said photo-stabilized silver agent is silver nitrate, silver acetate or silver lactate, or any combination thereof.

3. The dressing of claim 1 , wherein said compound containing a basic nitrogen atom is D,L-pyroglutamic acid.

4. The dressing of claim 3 , wherein said dye is Brilliant Green, Malachite Green, Methylene Blue, Ethyl Violet, Crystal Violet, Victoria Blue R, Victoria Blue B or Victoria Pure Blue BO, or any combination thereof.

5. The dressing of claim 3 , wherein said dye is Brilliant Green.

6. The dressing of claim 1 , wherein said dressing is provided as an I.V. dressing, a wound dressing, a wound barrier, a strip, a first aid bandage or a surgical drape.

7. The dressing of claim 1 , wherein said dressing has a thickness of up to about 5 mm.

8. A dressing consisting of

(a) a transparent and self-adhesive gel sheet cured from a liquid containing silicone and formed for adhesion to a wound site or surgical site on a patient, the cured gel sheet formed of a crosslinked silicone elastomer having sufficient crosslinking between silicone polymer chains so that the gel sheet is cohesively strong thereby allowing for application and subsequent removal from the wound site or surgical site while leaving substantially no residue, the cured gel sheet having from 95 wt % to 98 wt % of the crosslinked silicone elastomer and having evenly dispersed throughout the crosslinked silicone elastomer (i) solid particulates of chlorhexidine diacetate that is not soluble in said liquid, at a concentration so as not to disrupt the crosslinking between silicone polymer chains and the self-adhesiveness and cohesive strength of the gel sheet; and (ii) chlorhexidine digluconate, and a silver agent, the silver agent photo-stabilized with a compound containing a basic nitrogen atom to complex with the silver and a dye; the total amount of chlorhexidine present in the cured gel sheet being from 2 wt % to 5 wt %, and the amount of the silver agent present in the cured gel sheet being from 0.025 wt % to 0.5 wt %; and

(b) a non-adhesive, moisture vapor permeable backing layer layered on a bottom surface of the cured gel sheet, the top surface of the cured gel sheet being able to adhere to the skin of a subject without any additional adhesive.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 30, 2021
From: HSBC BANK CANADA
To: COVALON TECHNOLOGIES INC.
Reel/Frame 057039/0414 →
SECURITY INTEREST Recorded Aug 13, 2018
From: COVALON TECHNOLOGIES INC.
To: HSBC BANK CANADA
Reel/Frame 046627/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2011
From: YANG, LIU; DITIZIO, VALERIO
To: COVALON TECHNOLOGIES INC.
Reel/Frame 026457/0498 →
Continuity (2)
Provisional Application 61355725 · Jun 17, 2010
Related Publication 20110313048A1 · Dec 22, 2011
Cited By (2)
US 12,290,655 US 12,458,540